Low-Dose Catheter-Directed Thrombolysis for Massive Pulmonary Embolism: A Case Report Highlighting Dosing Considerations in Asian Patients.

IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS
Case Reports in Cardiology Pub Date : 2025-11-29 eCollection Date: 2025-01-01 DOI:10.1155/cric/3210422
Zhongjian Tang, Yang Song, Min Zhang, Mengyan Li, Jingjing Shang, Aiya Shu, Kunkun Wang, Yun Lucy Lu
{"title":"Low-Dose Catheter-Directed Thrombolysis for Massive Pulmonary Embolism: A Case Report Highlighting Dosing Considerations in Asian Patients.","authors":"Zhongjian Tang, Yang Song, Min Zhang, Mengyan Li, Jingjing Shang, Aiya Shu, Kunkun Wang, Yun Lucy Lu","doi":"10.1155/cric/3210422","DOIUrl":null,"url":null,"abstract":"<p><p>Clinical management of massive pulmonary embolism is challenging when active hemorrhage, a contraindication to thrombolytics, is concurrently present. We describe a successful attempt in using low-dose catheter-directed thrombolysis (CDT) in a high-risk patient with absolute contraindications to systemic thrombolysis. A 69-year-old Asian female with cardiac arrest was brought to a resource-limited rural hospital. The patient underwent 50 min of cardiopulmonary resuscitation (CPR) before regaining the pulse but remained in cardiogenic shock. Computerized tomography (CT) of the chest found massive PE. The patient was found with multiple fractures and subarachnoid hemorrhage. Catheter-directed embolectomy was performed without clinical improvement. A low-dose CDT with alteplase was attempted by giving 5 mg over 2 h with a repeated session 24 h later for a total of 10 mg. The patient started improving, was extubated on Day 9, and transferred out of the ICU on Day 15. Low-dose CDT in massive PE could be lifesaving despite the presence of absolute alteplase contraindications. Patients with contraindications, a high risk of bleeding, or of Asian race may benefit more from the low-dose alteplase regimen.</p>","PeriodicalId":51760,"journal":{"name":"Case Reports in Cardiology","volume":"2025 ","pages":"3210422"},"PeriodicalIF":0.5000,"publicationDate":"2025-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12681412/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/cric/3210422","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Clinical management of massive pulmonary embolism is challenging when active hemorrhage, a contraindication to thrombolytics, is concurrently present. We describe a successful attempt in using low-dose catheter-directed thrombolysis (CDT) in a high-risk patient with absolute contraindications to systemic thrombolysis. A 69-year-old Asian female with cardiac arrest was brought to a resource-limited rural hospital. The patient underwent 50 min of cardiopulmonary resuscitation (CPR) before regaining the pulse but remained in cardiogenic shock. Computerized tomography (CT) of the chest found massive PE. The patient was found with multiple fractures and subarachnoid hemorrhage. Catheter-directed embolectomy was performed without clinical improvement. A low-dose CDT with alteplase was attempted by giving 5 mg over 2 h with a repeated session 24 h later for a total of 10 mg. The patient started improving, was extubated on Day 9, and transferred out of the ICU on Day 15. Low-dose CDT in massive PE could be lifesaving despite the presence of absolute alteplase contraindications. Patients with contraindications, a high risk of bleeding, or of Asian race may benefit more from the low-dose alteplase regimen.

Abstract Image

低剂量导管定向溶栓治疗巨大肺栓塞:一个病例报告强调亚洲患者的剂量考虑。
当活动性出血(溶栓药物的禁忌症)同时存在时,大量肺栓塞的临床管理是具有挑战性的。我们描述了一个成功的尝试使用低剂量导管定向溶栓(CDT)在高危患者的绝对禁忌症,以全身溶栓。一名心脏骤停的69岁亚洲女性被送往资源有限的农村医院。患者在恢复脉搏前接受了50分钟的心肺复苏术,但仍处于心源性休克状态。胸部电脑断层扫描(CT)发现大量PE。患者发现多处骨折和蛛网膜下腔出血。导管导向的栓子切除术无临床改善。用阿替普酶进行低剂量CDT治疗,在2小时内给予5mg, 24小时后重复一次,总共10mg。患者病情开始好转,第9天拔管,第15天转出ICU。尽管存在阿替普酶的绝对禁忌症,但大范围PE的低剂量CDT仍可挽救生命。有禁忌症、出血风险高或亚洲人种的患者可能从低剂量阿替普酶方案中获益更多。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Case Reports in Cardiology
Case Reports in Cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
自引率
0.00%
发文量
63
审稿时长
13 weeks
期刊介绍: Case Reports in Cardiology is a peer-reviewed, Open Access journal that publishes case reports and case series related to hypertension, arrhythmia, congestive heart failure, valvular heart disease, vascular disease, congenital heart disease and cardiomyopathy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书